New pill tested to calm schizophrenia Flare-Ups
NCT ID NCT06179108
Summary
This study tested whether a new daily pill called LB-102 could help reduce symptoms in adults hospitalized with a sudden worsening of schizophrenia. About 360 participants were randomly assigned to receive either the drug at different doses or a placebo (a pill with no medicine) for 28 days. The main goal was to see if LB-102 was better than the placebo at lowering overall symptom scores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Behavioral Clinical Research, Inc.
Hollywood, Florida, 33021, United States
-
CelExel CNS
Garden Grove, California, 92845, United States
-
CelExel Clinical Innovations
Bellflower, California, 90706, United States
-
CenExel ACMR
Atlanta, Georgia, 30331, United States
-
CenExel CBH
Gaithersburg, Maryland, 20877, United States
-
CenExel CIT Riverside
Riverside, California, 92506, United States
-
CenExel HRI
Berlin, New Jersey, 08009, United States
-
CenExel RCA
Hollywood, Florida, 33024, United States
-
CenExel iResearch
Decatur, Georgia, 30030, United States
-
Community Clinical Research
Austin, Texas, 78754, United States
-
InSite Clinical Research
DeSoto, Texas, 75115, United States
-
Midwest Clinical Research Center
Dayton, Ohio, 45417, United States
-
NRC Research Institute
Santa Ana, California, 92705, United States
-
Neuro-Behavioral Clinical Research
North Canton, Ohio, 44720, United States
-
Pillar Clinical Research
Bentonville, Arkansas, 72712, United States
-
Pillar Clinical Research
Chicago, Illinois, 60641, United States
-
Pillar Clinical Research
Richardson, Texas, 75080, United States
-
ProScience Research Group
Culver City, California, 90230, United States
-
Richmond Behavioral Associates
Staten Island, New York, 10314, United States
-
Segal Institute for Clinical Research
Miami Lakes, Florida, 33016, United States
-
Synergy Research
Lemon Grove, California, 91945, United States
-
Synexus
Cerritos, California, 90703, United States
-
Uptown Research Institute
Chicago, Illinois, 60640, United States
-
Woodland Internation Research Group
Little Rock, Arkansas, 72211, United States
-
Woodland Research Northwest
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.